These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17951923)

  • 1. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.
    Shanmugam MP; Mythri HM; Shetty NS
    Indian J Ophthalmol; 2007; 55(6):490-1. PubMed ID: 17951923
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N; Vishwanathan K; Gupta V; Singh R; Gupta A
    Indian J Ophthalmol; 2007; 55(6):457-8. PubMed ID: 17951904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.
    Theodossiadis PG; Grigoropoulos VG; Emfietzoglou I; Vergados J; Chalkiadakis J; Theodossiadis GP
    Eur J Ophthalmol; 2007; 17(5):853-6. PubMed ID: 17932868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
    Mandal S; Sinha S; Abbas Z; Venkatesh P
    Indian J Ophthalmol; 2011; 59(4):338-9. PubMed ID: 21666337
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.
    Maia OO; Bonanomi MT; Takahashi WY; Nascimento VP; Takahashi BS
    Am J Ophthalmol; 2007 Aug; 144(2):296-9. PubMed ID: 17659962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necessity of paracentesis before or after intravitreal injection of bevacizumab.
    Huang WC; Lin JM; Chiang CC; Tsai YY
    Arch Ophthalmol; 2008 Sep; 126(9):1314-5; author reply 1315. PubMed ID: 18779502
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.
    Ben Yahia S; Herbort CP; Jenzeri S; Hmidi K; Attia S; Messaoud R; Khairallah M
    Int Ophthalmol; 2008 Aug; 28(4):311-6. PubMed ID: 18401552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
    Derriman L; Marshall J; Moorman C; Downes SM
    Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal neovascularization in pathologic myopia.
    Dave V; Narayanan R
    Am J Ophthalmol; 2010 Nov; 150(5):752; author reply 752-3. PubMed ID: 21036211
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.
    Raffa L; Bawazeer A
    Can J Ophthalmol; 2009 Oct; 44(5):615-6. PubMed ID: 19789612
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab for myopic choroidal neovascularization.
    Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A.
    Mavrakanas N; Mendrinos E; Pournaras CJ; Salzmann J
    Acta Ophthalmol; 2009 Nov; 87(8):930-2. PubMed ID: 19706015
    [No Abstract]   [Full Text] [Related]  

  • 19. Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab.
    Mones JM; Lopez MA; Prieto JA; Rodriguez JP
    Ophthalmic Surg Lasers Imaging; 2007; 38(3):226-8. PubMed ID: 17552389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab.
    Malik A; Sood S; Narang S
    Int Ophthalmol; 2010 Aug; 30(4):425-8. PubMed ID: 20049508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.